Quantcast

Latest pharmaceutical industry Stories

2014-07-29 23:05:06

MarketReportsOnline.com adds "Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition)" report to its research store. Dallas, Texas (PRWEB) July 29, 2014 This Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition) not only provided a comprehensive and thorough knowledge of the latest Chinese regulations on clinical trials for imported drug registration but also introduced...

2014-07-29 23:03:41

New Treatments Can Significantly Transform the Face of Hep C LA JOLLA, Calif. (PRWEB) July 29, 2014 CHI-California Healthcare Institute today unveiled a report that provides a comprehensive overview of the hepatitis C (hep C) epidemic in the U.S., the rise of treatments and the potential of these treatments to reduce human suffering. The report examines key data to provide a broader understanding of the impact of hep C, while highlighting the significance of breakthroughs that have...

2014-07-29 23:03:01

SafeUseNow to demonstrate how its predictive analytics can be used to identify and help mitigate prescription drug abuse risk ENCINITAS, Calif. (PRWEB) July 29, 2014 July 29, 2014 - What if you could stop prescription drug abuse directly at the source? That’s the big public health question being addressed by SafeUseNow, an innovative prescription drug abuse risk program developed by Principled Strategies. SafeUseNow has been selected from hundreds of applicants worldwide to be part of...

2014-07-29 16:26:09

ARLINGTON, Va., July 29, 2014 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on today's passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2014 (H.R. 4709) by the House of Representatives. The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.) "Today's vote represents a victory for those working to curb our nation's prescription drug...

2014-07-29 12:35:35

TAMPA, Fla., July, 29 2014 /PRNewswire-USNewswire/ -- ISPE--the International Society for Pharmaceutical Engineering announced today it has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience. He brings to the Society a clear vision for the expansion of its global...

2014-07-29 08:34:18

New pharmaceutical development opens up entry into blockbuster markets SALT LAKE CITY and TORONTO, July 29, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules announces expansion of its pharmaceutical development implementing its sub-micron platform technology. The company's...

2014-07-29 08:32:54

Phase I Project to Focus on Advanced Molecular Search Models for the Inverse Design Computational Drug Discovery Platform RESEARCH TRIANGLE PARK, N.C., July 29, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. The grant is valued at $150,000. Cloud...

2014-07-29 08:32:31

HAYWARD, Calif., July 29, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a general GMP inspection and a Pre-Approval Inspection (PAI) for RYTARY(TM )at the Company's Taiwan manufacturing facility from July 21 to July 26, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with ten inspectional observations. The Taiwan facility was approved for product manufacturing by the FDA in...

2014-07-29 08:32:30

BELLEVILLE, ON, July 29, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, an application for Orphan Drug Designation for its Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory/relapsing high grade non-muscle invasive bladder cancer. The decision to proceed...

2014-07-28 23:04:08

Transparency Market Research has published a new report titled "Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html. Albany, New York (PRWEB) July 28, 2014 According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related